This is a Validated Antibody Database (VAD) review about mouse Cyp24a1, based on 6 published articles (read how Labome selects the articles), using Cyp24a1 antibody in all methods. It is aimed to help Labome visitors find the most suited Cyp24a1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cyp24a1 synonym: 24-OHase; CP24; Cyp24; 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial; 25-hydroxyvitamin D-24-hydroxylase; cytochrome P450 24A1; cytochrome P450, 24; cytochrome P450, 24a1; cytochrome P450-CC24; vitamin D(3) 24-hydroxylase
Cell Signaling Technology
rabbit monoclonal (D12B2) |
| In order to explore the role of Axl in promoting a suppressive myeloid microenvironment in response to ionizing radiation therapy in combination with checkpoint immunotherapy, Cell Signaling Technology Cyp24a1 antibody (Cell Signaling, 5724) was used in western blot on mouse samples at 1:1000 (fig 4e). Nat Commun (2016) ncbi |
rabbit monoclonal (D12B2) |
| In order to engineer and characterize a second-generation, high-affinity AXL decoy receptor, Cell Signaling Technology Cyp24a1 antibody (CST, 5724) was used in western blot on mouse samples (fig 4d). J Clin Invest (2017) ncbi |
rabbit monoclonal (D12B2) |
| Cell Signaling Technology Cyp24a1 antibody (Cell Signaling, 5724) was used in western blot on human samples (fig 2a, 2b, 2c). Oncotarget (2016) ncbi |
rabbit monoclonal (D12B2) |
| Cell Signaling Technology Cyp24a1 antibody (cell signalling, 5724) was used in western blot on human samples (fig 4c). Oncotarget (2016) ncbi |
rabbit monoclonal (D12B2) |
| Cell Signaling Technology Cyp24a1 antibody (Cell Signaling, 5724) was used in western blot on human samples (fig 3). Int J Cancer (2016) ncbi |
rabbit monoclonal (D12B2) |
| Cell Signaling Technology Cyp24a1 antibody (Cell Signaling Technology, 5724) was used in western blot on human samples (fig 6). Oncogene (2016) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments